Vanda Pharmaceuticals, Inc. (VNDA) Posts Wider than Expected Q3 Loss

November 7, 2013 6:58 AM

Vanda Pharmaceuticals, Inc. (NASDAQ: VNDA) reported Q3 EPS of ($0.43) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found